SCIENTIFIC ADVISORY

2019-     Janssen Pharmaceuticals (Consultation): Development of gene therapy for inherited retinal disease

2019-     NightStar (Consultation): Development of gene therapy for inherited retinal disease

2018-     Sanofi Genzyme (Consultation): Development of gene therapy for inherited retinal disease

2018-     Novartis AG (Consultation): Development of gene therapy for inherited retinal disease

2018-     Acucela Inc., (Consultation): Development of gene therapy and compound therapy for inherited retinal disease

2017-    Kubota Pharmaceutical Holdings Co., Ltd, (Consultation): Development of gene therapy and compound therapy for inherited retinal disease